West Pharmaceutical Services Inc
WST· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2012 | Q3 2011 | Q3 2010 | Q3 2009 |
|---|---|---|---|---|
| Revenue | $303.80M | $293.60M | $271.40M | $258.90M |
| Net Income | $14.80M | $16.90M | $17.80M | $17.20M |
| EPS Diluted | $0.21 |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $0.49 |
| $0.51 |
| $0.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.